These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32339432)

  • 1. Biomarkers versus viscoelastic testing for the detection of fibrinolysis.
    Görlinger K
    ANZ J Surg; 2020 Apr; 90(4):411-412. PubMed ID: 32339432
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance and practical assessment of fibrinolysis shutdown.
    Moore HB; Moore BA; Sauaia A; Moore EE
    ANZ J Surg; 2020 Apr; 90(4):413-414. PubMed ID: 31535453
    [No Abstract]   [Full Text] [Related]  

  • 3. The S100A10 Pathway Mediates an Occult Hyperfibrinolytic Subtype in Trauma Patients.
    Gall LS; Vulliamy P; Gillespie S; Jones TF; Pierre RSJ; Breukers SE; Gaarder C; Juffermans NP; Maegele M; Stensballe J; Johansson PI; Davenport RA; Brohi K;
    Ann Surg; 2019 Jun; 269(6):1184-1191. PubMed ID: 31082919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reactions of alpha 2 plasmin inhibitor to plasmin and fibrin; its significance in fibrinolysis inhibition and hemostasis].
    Ichinose A; Sakata Y; Aoki N
    Rinsho Byori; 1982 Jun; Suppl 50():178-88. PubMed ID: 6215510
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemostasis in newborns of smoking and nonsmoking mothers.
    Mercelina-Roumans PE; Ubachs JM; van Wersch JW
    Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
    Madoiwa S
    Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
    Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.
    Kambayashi J; Sakon M; Yokota M; Shiba E; Kawasaki T; Mori T
    Thromb Res; 1990 Oct; 60(2):157-67. PubMed ID: 2149215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory measures of hemostasis and fibrinolysis after intravenous administration of epsilon-aminocaproic acid in clinically normal horses and ponies.
    Heidmann P; Tornquist SJ; Qu A; Cebra CK
    Am J Vet Res; 2005 Feb; 66(2):313-8. PubMed ID: 15757133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating prethrombotic state in lung cancer using molecular markers.
    Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilia in sickle cell disease: the red cell connection.
    Setty BN; Rao AK; Stuart MJ
    Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory tests of coagulation and fibrinolysis for the diagnosis of rheumatoid arthritis].
    Koshihara K; Fukutake K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():358-61. PubMed ID: 15799378
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo.
    Noda Y; Nakamura M; Sasaki M; Kosugi T
    Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis.
    Reed GL; Matsueda GR; Haber E
    Trans Assoc Am Physicians; 1991; 104():21-8. PubMed ID: 1845147
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism.
    Kodama H; Fukuda J; Karube H; Matsui T; Shimizu Y; Tanaka T
    Fertil Steril; 1995 Dec; 64(6):1207-9. PubMed ID: 7589679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia.
    Hinterhuber G; Böhler K; Kittler H; Quehenberger P
    Dermatol Surg; 2006 May; 32(5):632-9. PubMed ID: 16706757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of fibrinogenolysis in patients with closed head injury.
    Kushimoto S; Shibata Y; Yamamoto Y
    J Neurotrauma; 2003 Apr; 20(4):357-63. PubMed ID: 12866815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin--alpha 2-antiplasmin complex as an indicator of in vivo fibrinolysis.
    Booth NA; Bennett B
    Br J Haematol; 1982 Mar; 50(3):537-41. PubMed ID: 6461348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.